We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 24 NOVEMBER 2023
PMPRB Publishes Scoping Paper For The Consultations On The Board's Guidelines To Streamline Policy Roundtable
DLA Piper
The Patented Medicines Prices Review Board ("PMPRB") is responsible for ensuring that the prices of patented medicines in Canada are not excessive.
CanadaIntellectual Property






